Quick Takeaways
- YA II PN, Ltd. filed SCHEDULE 13G for Indaptus Therapeutics, Inc. Common Stock (INDP).
- Disclosed ownership: 10%.
- Date of event: 13 Feb 2025.
Quoteable Key Fact
"YA II PN, Ltd. disclosed 10% ownership in Indaptus Therapeutics, Inc. Common Stock (INDP) on 13 Feb 2025."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original Filing| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| YA II PN, Ltd. | 10% | 1,410,916 | 0 | 1,410,916 | /s/ David Gonzalez | David Gonzalez, General Counsel | |
| YA Global Investments II (U.S.), LP | 10% | 1,410,916 | 0 | 1,410,916 | /s/ David Gonzalez | David Gonzalez, General Counsel | |
| Yorkville Advisors Global, LP | 10% | 1,410,916 | 0 | 1,410,916 | /s/ David Gonzalez | David Gonzalez, General Counsel | |
| Yorkville Advisors Global II, LLC | 10% | 1,410,916 | 0 | 1,410,916 | /s/ David Gonzalez | David Gonzalez, General Counsel | |
| YAII GP, LP | 10% | 1,410,916 | 0 | 1,410,916 | /s/ David Gonzalez | David Gonzalez, General Counsel | |
| YAII GP II, LLC | 10% | 1,410,916 | 0 | 1,410,916 | /s/ David Gonzalez | David Gonzalez, General Counsel | |
| Mark Angelo | 10% | 1,410,916 | 0 | 1,410,916 | /s/ Mark Angelo | Mark Angelo | |
| SC-Sigma Global Partners, LP | 10% | 1,410,916 | 0 | 1,410,916 | /s/ David Gonzalez | David Gonzalez, General Counsel |